Published Mar 13, 2023
Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]
Peter Attia delves into the multifaceted uses of metformin and GLP-1 agonists, discussing metformin's emerging role as a geroprotective agent and the weight loss potential of semaglutide and tirzepatide. He highlights the hormonal and insulin-related impacts of these drugs, considering their growing popularity beyond traditional diabetes treatment.
